BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, today announced the first patients outside of a clinical trial have been successfully implanted with the BTG Sentry ...
Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Use of a bioconvertible inferior vena cava filter successfully prevented new-onset pulmonary ...
BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...
If you have had a deep vein thrombosis (DVT), you may worry about having another life-threatening clot. People who’ve had a DVT and can’t take blood-thinning medications have another option to prevent ...
Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...
FAIRFAX, Va.—Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results